Clinical features and molecular phenotypes of breast cancer in patients with type-2 diabetes mellitus

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 9, 2011, Pages 2183-2188

  Li, Zhihua ^a   Luo, Yonghui ^a   Gong, Yu ^a   Liu, Yonghua ^a   Qiu, Wei ^a   Tu, Jianhong ^a  

^a The Third Hospital of Nanchang City   (China)

Author keywords

Breast cancer; Clinical features; Diabetes mellitus; Hyperinsulinemia; Molecular phenotype

Indexed keywords

INSULIN;

ADJUVANT THERAPY; ARTICLE; BLOOD; BREAST TUMOR; CANCER STAGING; CASE CONTROL STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HYPERINSULINISM; LYMPH NODE METASTASIS; METHODOLOGY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; POSTMENOPAUSE; PROGNOSIS; RETROSPECTIVE STUDY; RISK;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERINSULINISM; INSULIN; LYMPHATIC METASTASIS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; POSTMENOPAUSE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK;

EID: 84866273394     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Baron JA, Weiderpass E, Newcomb PA, et al (2001). Metabolic disorders and breast cancer risk (United States). Cancer Causes Control, 12, 875-80.
2. Barone BB, Yeh HC, Snyder CF, et al (2008). Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA, 300, 2754-64.
3. Carey LA, Perou CM, Livasy CA, et al (2006). Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA, 295, 2492-502.
4. Erickson K, Patterson RE, Flatt SW, et al (2011). Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer. J Clin Oncol, 29, 54-60.
5. Goodwin PJ, Ennis M, Pritchard KI, et al (2002). Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol, 20, 42-51.
6. Gouveri E, Papanas N, Maltezos E (2011). The female breast and diabetes. Breast, 20, 205-11.
7. Guastamacchia E, Resta F, Mangia A, et al (2003). Breast cancer: biological characteristics in postmenopausal type 2 diabetic women. Identification of therapeutic targets. Curr Drug Targets Immune Endocr Metabol Disord, 3, 205-9.
8. Inoue M, Iwasaki M, Otani T, et al (2006). Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med, 166, 1871-7.
9. Larsson SC, Mantzoros CS, Wolk A (2007). Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer, 121, 856-62.
10. Liao S, Li J, Wang L, et al (2010). Type 2 diabetes mellitus and characteristics of breast cancer in China. Asian Pac J Cancer Prev, 11, 933-7.
11. Lipscombe LL, Goodwin PJ, Zinman B, et al (2006). Diabetes mellitus and breast cancer: a retrospective population-based cohort study. Breast Cancer Res Treat, 98, 349-56.
12. Michels KB, Solomon CG, Hu FB, et al (2003). Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care, 26, 1752-8.
13. Novosyadlyy R, Lann DE, Vijayakumar A, et al (2010). Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes. Cancer Res, 70, 741-51.
14. Nyholm H, Djursing H, Hagen C, et al (1989). Androgens and estrogens in postmenopausal insulin-treated diabetic women. J Clin Endocrinol Metab, 69, 946-9.
15. Pasanisi P, Berrino F, De Petris M, et al (2006). Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer, 119, 236-8.
16. Peairs KS, Barone BB, Snyder CF, et al (2011). Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J Clin Oncol, 29, 40-6.
17. Pisani P (2008). Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Arch Physiol Biochem, 114, 63-70.
18. Schott S, Schneeweiss A, Sohn C (2010). Breast cancer and diabetes mellitus. Exp Clin Endocrinol Diabetes, 118, 673-7.
19. Schrauder MG, Fasching PA, Haberle L, et al (2011). Diabetes and prognosis in a breast cancer cohort. J Cancer Res Clin Oncol, 137, 975-83.
20. Seshasai SR, Kaptoge S, Thompson A, et al (2011). Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med, 364, 829-41.
21. Shipitsin M, Campbell LL, Argani P, et al (2007). Molecular definition of breast tumor heterogeneity. Cancer Cell, 11, 259-73.
22. Srokowski TP, Fang S, Hortobagyi GN, Giordano SH (2009). Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer. J Clin Oncol, 27, 2170-6.
23. Tseng CH, Chong CK, Tai TY (2009). Secular trend for mortality from breast cancer and the association between diabetes and breast cancer in Taiwan between 1995 and 2006. Diabetologia, 52, 240-6.
24. Verlato G, Zoppini G, Bonora E, Muggeo M (2003). Mortality from site-specific malignancies in type 2 diabetic patients from Verona. Diabetes Care, 26, 1047-51.
25. White MF (2003). Insulin signaling in health and disease. Science, 302, 1710-11.
26. Wolf I, Sadetzki S, Catane R, et al (2005). Diabetes mellitus and breast cancer. Lancet Oncol, 6, 103-11.